retatrutide clinical trial saudi arabia FDA Approval Status 2026: Everything We Know So Far Retatrutide Phase 3: 60% Achieved

Dysesthesia Dysesthesia refers to unusual skin sensations, such as tingling, prickling, burning, or altered sensitivity

Its becoming more clear how damaging visceral fat is because it contributes to diabetes, fatty liver disease, kidney disease, and cardiovascular disease

doi: 10.1093/jn/133.3.838S, 30 DrokhlyanskyE.SmillieC

For most folks its a cosmetic issue and nothing more

Raj Dasgupta, MD, FACP, FCCP, FAASM, board-certified in pulmonary, sleep, internal, and critical care medicine and chief medical advisor for Sleepopolis, isnt prescribing GLP-1s, but he will refer OSA patients to an endocrinologist if he believes they might benefit from a GLP-1

Despite high upfront costs, economic modeling suggests potential long-term value